Skip to main content

One-session bilateral sequential whole lung lavage (OSBSWLL) for the management of pulmonary alveolar proteinosis

Abstract

Background

Whole Lung Lavage (WLL) has been an important part in the management of Pulmonary Alveolar Proteinosis (PAP) since it improves radiologic and clinical parameters. Bilateral WLL is usually performed in two sessions on different days. Few case reports have described one-session bilateral sequential lung lavage (OSBSWLL), and none have described ambulatory management (same-day discharge).

Methods

Demographic characteristics, physiologic parameters, procedure details and outcomes were retrospectively collected on consecutive patients who underwent OSBSWLL for PAP following an ambulatory protocol stablished in our institution.

Results

A total of 13 patients underwent 30 OSBSWLL (61.5% male; mean age 40). The mean SpO2 was 90% (IQR 9) and 94% (IQR 6), before and after OSBSWLL respectively. In 63.3% of cases, patients were discharged home the same day of procedure. Only in two cases (6.6%), patients required post-procedure prolonged mechanical ventilation (> 4 h) due to persistent hypoxia.

Conclusions

OSBSWLL can be performed with same-day discharge.

Peer Review reports

Introduction

Pulmonary Alveolar Proteinosis (PAP) was recognized by Rosen in 1958 [1]. It is a rare entity with a prevalence between 3.2 to 6.7 cases per million [2, 3]. More than 90% of PAP cases occur as primary acquired disorders of unknown etiology [1].

The diagnosis of PAP is based on the clinical suspicion and radiologic findings (bilateral and symmetrical confluent airspace disease [4], and/or “crazy paving” pattern seen on computed tomography [5]. The bronchoalveolar lavage effluent has a turbid and milky appearance due to the presence of foamy macrophages or monocyte-like alveolar macrophages with an increased number of lymphocytes. These changes are associated with a large periodic acid-Shift (PAS) positive acellular background of diffuse eosinophilic bodies [4, 6], which is diagnostic of PAP. The presence of lamellar bodies under electron microscope examination can be used to confirm the diagnosis. These abnormalities translate into an enormous accumulation of surfactant lipoprotein in pulmonary alveoli leading to the clinical findings of increase alveolar-arterial oxygen gradient and hypoxemia.

Whole Lung Lavage (WLL), first described by Ramirez-Rivera in 1965 [7], is currently the first line therapy for PAP. This procedure is performed to remove the excess surfactant proteins and lipids from the alveolar spaces in order to improve gas exchange. Most published case series, as well as a recent global survey, have shown that most centers perform WLL on two separate sessions [8]. In our institution, we have been performing bilateral, sequential WLL on one session (OSBSWLL) since 1994, although inconsistently initially, it became more consistent over the past 15 years. We believe that OSBSWLL is safe to perform, comfortable for the patient, and could reduce costs of a second procedural session. Per our knowledge, this is the largest case series of OSBSWLL reported.

Methods

We retrospectively reviewed the medical records of patients who underwent WLL due to PAP from 1994 until 2013 at Henry Ford Hospital. Our Institutional Review Committee (IRB) had approved this study (IRB-9021) in accordance with the relevant guidelines and regulations. A total of 25 consecutive patients who underwent WLL were identified. All patients had biopsy proven PAP. 13 patients underwent a total of 30 OSBSWLL. Data regarding demographics, clinical presentation, procedure, and complications were collected (Table 1).

Table 1 General demographics

Procedure/technique

Before lavage

All OSBSWLL are performed in the Operating Room (OR) under general anesthesia. The team involved in the procedure include: an interventional pulmonologist, an anesthesiologist, respiratory therapists, and experienced operating room assistants. In the operating room, general anesthesia and muscle paralysis are induced by the anesthesiologist. The patient is placed in a supine position and intubated with a 39 Fr double-lumen endotracheal tube (dETT) (or smaller depending on the size of patient). After the position of the dETT in the airways is confirmed by flexible bronchoscopy (pediatric scope), the dETT is secured in place. A “leak test” is then performed: a single lumen endotracheal tube is attached to a connector allowing it to be secured to the dETT, with the tip placed in a bottle of saline, which will hence be referred to as the leak test kit (LTK). Initially one side of the dETT is connected to the LTK and the other to the ventilator. Airway pressures are increased by the ventilator and held sequentially at 20, 30 and 40 cm H2O. The airway pressures are then fluctuated between 40 and 50 cm H2O looking for bubbling in the saline from the end of the LTK. If no bubbling is observed, the process is repeated on the opposite side of the dETT. If both “leak tests” are negative, we proceed to stabilize the head of patient and tubing system by using towels, blankets and padding to avoid pressure ulcers on the patient’s face and skin (Fig. 1). The flexible bronchoscope is then used to confirm positioning one more time.

Fig. 1
figure 1

Patient intubated with a double lumen endotracheal tube supported by towels achieving airway stabilization and protection of patient soft tissue areas over the neck, face and head

The patient is then oxygenated with 100% FiO2 to both lungs for 10 min. After the first lung to be lavaged is determined (the lung with the greater disease burden by imaging), we proceed to the “degassing maneuver”. For this, the corresponding arm of the dETT is closed using a curved Kelly clamp. The dETT remains clamped for 5 min to allow degassing of the lung. [9] The customized tubing system to be used for the lavage (Fig. 2) is prepared, ensuring that it is air-free. It is then connected to the appropriate arm of the dETT. Multiple three-liter bags of normal saline had been previously warmed to a temperature of 37 °C. The bags are then hung 40 cm above the level of the heart.

Fig. 2
figure 2

A Tubing setting. B Tubing setting seen on patient during procedure

Lavage

We start the lavage by instilling two liters of the warmed normal saline, by gravity, into the lung through the tubing system. Cardiopulmonary physical therapists provide manual percussion of the chest throughout the procedure in order to achieve better mobilization and subsequently improved removal of particulate matter and instilled fluid. After the first two liters are instilled into the lung, the inflow portion of the tubing circuit is closed and the effluent from the lung is drained by gravity into a suction canister which is calibrated by milliliters. Initially, one liter of effluent is drained and one liter of saline remains in the lung to maintain patency of the lung. The process of instillation and drainage is repeated using one-liter aliquots for both the in and out portions of the procedure. Visible clearing of the effluent is used as the marker to stop the lavage. Effluent clearing usually requires approximately 16 L of fluid per lung. When the effluent has cleared enough (Fig. 3), the final drainage will include the one liter of initially instilled into the lung.

Fig. 3
figure 3

Example of visual assessment of returned lavage. R1: first returned lavage, right lung. R17: 17th returned lavage, right lung

The patient is then reassessed to decide if the procedure for the second lung can safely be completed. Assessment of vital signs, including pulsoximetry, as well as bronchoscopic confirmation of the dETT are done before moving on to the second lung. Then we proceed to perform the “degassing maneuver” on the second lung (as described above).

The amount of fluid instilled and removed is carefully ascertained at the completion of each lung and then for a total for the procedure. The “final balance of fluid” (total amount of fluid instilled into the lungs minus amount of fluid recovered from the lungs) is recorded.

After lavage

At procedure terminus, the double-lumen tube is removed and a #8 single-lumen ETT is placed (depending on the size of patient). The patient is maintained on mechanical ventilation for 4 h following the procedure. For the first 2 h on an FiO2 of 100% and for the second 2 h weaned to 30%. If patients are assessed to be clinically doing well with adequate SaO2 they are discharged home the same day of the procedure. Patients admitted to the hospital overnight will be weaned to room air prior to discharge. All patients are scheduled for outpatient follow up within 1 to 2 weeks.

Results

Thirteen patients underwent a total of 30 OSBSWLL (mean of 2.3 OSBSWLL per patient, IQR 1). There were two other procedures scheduled initially as OSBSWLL, but they only completed a single WLL due to complications. These 2 cases were not included on the 30 OSBSWLL (Table 2).

Table 2 Procedures scheduled as OSBSWLL, but only completed lavage of one lung

Eight patients were male (61.5%). Nine were Caucasians (69.2%). PAP was diagnosed with Open Lung Biopsy (OLBX) in 8 patients (61.5%). The time from diagnosis of PAP to first OSBSWLL ranged from less than one year to 4 years (mean 1.38; IQR 0.5) (Table 1).

None of the patients were on mechanical ventilation before OSBSWLL, and only two were inpatients before the procedure (6.6%).

The time used for OSBSWLL was found in 17 procedures. The time varied between 135 and 274 min (mean of 208.1 min, IQR 42). The total amount of normal saline (in Liters) used per OSBSWLL ranged between 14.5 and 50.9 (mean of 31.1, IQR 15.3) with a range between 6 to 29.3 per lung (mean of 15.5 L). The final balance of fluid at the end of the procedure ranged between 0 and 2500 ml (mean of 781.8 ml, IQR 790).

Peripheral capillary oxygen saturation (SpO2) values on room air were found in 21 cases (15 pre-procedure, 19 post-procedure, and 13 in both). The mean SpO2 pre-procedure was 90% (IQR 9). The mean SpO2 in the immediate post-procedure was 94.8% (IQR 6). Among the cases with both values, the mean variation between the pre and post-procedure SpO2 was + 5.3% (IQR 9.5).

Eleven cases of OSBSWLL (36.6%) required post-procedure admission to the hospital. The most common cause for admission was observation for dyspnea (Table 3). The mean length of admission was 2.3 days (IQR 1). Only in 3 cases of OSBSWLL patients required admission to the Intensive Care Unit (two cases with 1 day and one case with 7 days) (Table 3).

Table 3 Procedure, indication and hospital admission per patient

In 19 cases of OSBSWLL (63.3%), the patients were discharged home the same day of procedure. About 1-year survival, 24 cases (80%) of OSBSWLL were alive after 1 year, 1 had died and 5 were unknown.

Discussion

It is known that WLL is the standard treatment for PAP, since it has a great efficacy to improve symptoms as well as other functional and radiological parameters [1]. There is still a lack of standardization of the indications for the procedure, the procedure itself and the outcomes [8].

Traditionally, most case series of PAP have mentioned the use of WLL in two separate sessions (one lung per session) [3, 4, 6, 8]. A global survey on WLL done in 20 centers in 14 countries revealed that most centers perform WLL in consecutive sessions (one lung per session), with an interval of 1 to 2 weeks between procedures [8]. No specific data has been published about OSBSWLL thus far.

In this case-series, we present our experience with OSBSWLL as part of the treatment for PAP. We believe this is the largest case-series report for OSBSWLL in the literature.

The most common indications to perform WLL described are: lung function decline, change in PaO2 or SpO2, worsening chest imaging (chest X-ray or computed tomography) and worsening dyspnea [3, 4, 8]. In our case-series, all the patients had dyspnea and worsening chest images before undergoing OSBSWLL. The mean SpO2 value before procedure was also low (90%).

The amount of fluid used per lung in our series has a great variation (6 to 29.3 Liters), which is comparable to other series (range between 1 and 40 Liters) [1, 8]. In our institution the lavage continues until the pulmonologist does a visual assessment of the color and sediment of the effluent demonstrating enough clarity to see the movement of fingers through the effluent (Fig. 3). Even though Bonella, et al. [10] used optical density monitoring to quantify protein content of the returned fluid as a tool on the decision to terminate the procedure, there is no data that compares optical density values against visual assessment of color and sediment done by an experienced physician.

The length of time to perform OSBSWLL ranged between 135 and 274 min in our case-series. The duration of single WLL reported by Campo et al. [8] ranged between 120 and 360 min. These results show very similar times between OSBSWLL and single WLL, which could be explained by the fact that the longest part of the procedure is dedicated to positioning the patient and securing/stabilizing the airway, which is the same in both procedures.

The post-procedure management in our cases is similar to other series. Abdelmalak, et al. [11] described an early weaning from the ventilator (within 4 h of finishing the procedure) and weaning of supplemental oxygen. In our series, 63.3% of cases were able to be weaned from ventilator and discharged home the same day of the procedure. In fact, SpO2 values improved by 5.3 points after the procedure; and all patients had a subjective improvement of dyspnea.

Complications reported in other series of WLL have included hypoxemia (which is usually transient, during the emptying of the lung being lavaged, that releases compression of the capillary bed, creating a shunt). Refractory hypoxemia and respiratory failure have been described, mostly related to lavage fluid absorption leading to pulmonary edema [11]. In our series, only 2 cases (6.6%) required mechanical ventilation longer than 4 h after OSBSWLL due to hypoxia. One of them, who was treated for pneumonia post-operatively, also had a large residual volume (2,500 mL) that could have contributed to hypoxia. Pneumothorax has also been described in WLL due to excessive alveolar distention [11]. Even though, none of the patients who underwent OSBSWLL developed pneumothorax, one of the patients who was initially scheduled for OSBSWLL could not complete lavage of the second lung due to hypoxia that was later deemed to be secondary to pneumothorax on the lavaged lung, which required a chest tube placement and admission to ICU. One patient died within 1-year post OSBSWLL, unfortunately no records were able to be collected in terms of cause of death.

We believe that OSBSWLL requires an experienced multidisciplinary team. Planning and communication with the members of the team are the key to the success of this procedure.

Although patients were captured from a prospective, IRB approved database, much of the data was extracted retrospectively. This limited the obtention of some data: clinical presentation, functional outcomes, time of procedure on all patients, overall because most data were recorded before electronic medical records were instituted. Furthermore, despite developing a protocol in our institution, some inconsistency was noted when OSBSWLL started to be performed. Despite all these limitations, we believe that our data can be used to improve future protocols for performing whole lung lavage.

Conclusions

OSBSWLL can be performed withinone procedure with a same-day discharge as part of the treatment for patients with diagnosis of PAP. OSBSWLL could be considered as part of the management on patients with PAP that require WLL in institutions with a stablished protocol. Standardization of procedural protocols should be developed among institutions.

Availability of data and materials

All data generated and analysed in this study are included in this article under related information files.

References

  1. 1.

    Gay P, Wallaert B, Nowak S, Yserbyt J, Stavros A, Hermant C, et al. Efficacy of whole-lung lavage in pulmonary alveolar proteinosis: a multicenter international study of GELF. Respiration. 2017;93(3):198–206.

    Article  Google Scholar 

  2. 2.

    Ben-Dov IKY, Rozman J, Soliman A, Bishara H, Zelligson E, Grief J, et al. Pulmonary alveolar proteinosis in Israel: ethnic clustering. Isr Med Assoc J. 1998;1:75–8.

    Google Scholar 

  3. 3.

    Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166:215–35.

    Article  Google Scholar 

  4. 4.

    Wang BM, Stern EJ, Schmidt RA, Pierson DJ. Diagnosing pulmonary alveolar proteinosis. A review and an update. Chest. 1997;111:460–6.

    CAS  Article  Google Scholar 

  5. 5.

    Lee KN, Levin DL, Webb WR, Chen D, Storto ML, Golden JA. Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations. Chest. 1997;111:989–95.

    CAS  Article  Google Scholar 

  6. 6.

    Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med. 2003;349:2527–39.

    CAS  Article  Google Scholar 

  7. 7.

    Ramirez J, Campbell GD. Pulmonary alveolar proteinosis. endobronchial treatment. Ann Intern Med. 1965;63:429–41.

    CAS  Article  Google Scholar 

  8. 8.

    Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters JC, et al. WLL international study group a global survey on whole lung lavage in pulmonary alveolar proteinosis. Chest. 2016;150(1):251–3.

    Article  Google Scholar 

  9. 9.

    Stengel PW, Frazer DG, Weber KC. Lung degassing: an evaluation of two methods. J Appl Physiol Respir Environ Exerc Physiol. 1980;48(2):370–5.

    CAS  PubMed  Google Scholar 

  10. 10.

    Bonella F, Bauer PC, Griese M, Wessendorf TE, Guzman J, Costabel U. Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis. Eur Respir J. 2012;40:1468–74.

    Article  Google Scholar 

  11. 11.

    Abdelmalak BB, Khanna AK, Culver DA, Popovich MJ. Therapeutic whole lung lavage for pulmonary alveolar proteinosis: a procedural update. J Bronchology Interv Pulmonol. 2015;22(3):251–8.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

No funding was received for this study.

Author information

Affiliations

Authors

Contributions

J.D.-M.: Conceptualization, Methodology, Investigation, Data curation, Writing-Review and Editing, Project administration. E.C.V.: Methodology, Investigation, Data curation, Writing-Original draft. N.P.: Methodology, Data curation, Writing-Original draft. M.S.: Conceptualization, Methodology, Writing-Review and Editing, Project administration. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Javier Diaz-Mendoza.

Ethics declarations

Ethics approval and consent to participate

The Henry Ford Health System Institutional Review Committee (IRB) had approved this study (IRB-9021). Being a retrospective study, the need of informed consent was waived by our IRB.

Consent for publication

Not applicable.

Competing interests

All the authors declare NON-COMPETING interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Diaz-Mendoza, J., Celis Valdiviezo, E., Patel, N.M. et al. One-session bilateral sequential whole lung lavage (OSBSWLL) for the management of pulmonary alveolar proteinosis. BMC Pulm Med 21, 358 (2021). https://doi.org/10.1186/s12890-021-01734-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12890-021-01734-w